• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症小体与代谢紊乱:古老基因与现代疾病。

Inflammasomes and metabolic disorders: old genes in modern diseases.

机构信息

The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

The Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

Mol Cell. 2014 Apr 24;54(2):297-308. doi: 10.1016/j.molcel.2014.03.029.

DOI:10.1016/j.molcel.2014.03.029
PMID:24766894
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4084585/
Abstract

Modern medical and hygienic practices have greatly improved human health and longevity; however, increased human life span occurs concomitantly with the emergence of metabolic and age-related diseases. Studies over the past decade have strongly linked host inflammatory responses to the etiology of several metabolic diseases including atherosclerosis, type 2 diabetes (T2D), obesity, and gout. A common immunological factor to these diseases is the activation of the inflammasome and release of proinflammatory cytokines that promote disease progression. Here we review the molecular mechanism(s) of inflammasome activation in response to metabolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic intervention.

摘要

现代医学和卫生实践极大地提高了人类的健康和寿命;然而,人类寿命的延长伴随着代谢和与年龄相关的疾病的出现。过去十年的研究强烈表明,宿主炎症反应与几种代谢疾病(包括动脉粥样硬化、2 型糖尿病(T2D)、肥胖症和痛风)的病因有关。这些疾病的一个共同的免疫学因素是炎症小体的激活和促炎细胞因子的释放,促进疾病的进展。在这里,我们回顾了炎症小体对代谢损伤相关分子模式(DAMPs)的激活的分子机制,并讨论了潜在的治疗干预靶点。

相似文献

1
Inflammasomes and metabolic disorders: old genes in modern diseases.炎症小体与代谢紊乱:古老基因与现代疾病。
Mol Cell. 2014 Apr 24;54(2):297-308. doi: 10.1016/j.molcel.2014.03.029.
2
Specific inflammasomes in complex diseases.特定炎症小体与复杂疾病。
Clin Immunol. 2013 Jun;147(3):223-8. doi: 10.1016/j.clim.2012.12.006. Epub 2012 Dec 21.
3
Inflammasome activation and metabolic disease progression.炎症小体激活与代谢性疾病进展。
Cytokine Growth Factor Rev. 2014 Dec;25(6):699-706. doi: 10.1016/j.cytogfr.2014.07.020. Epub 2014 Aug 12.
4
Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases.损伤相关分子模式驱动的代谢性疾病中的治疗机会
Antioxid Redox Signal. 2015 Dec 10;23(17):1305-15. doi: 10.1089/ars.2015.6383. Epub 2015 Jul 27.
5
[Inflammasome--essential regulator of the inflammatory reaction].[炎性小体——炎症反应的关键调节因子]
Duodecim. 2013;129(7):705-11.
6
Inflammasome activation in response to dead cells and their metabolites.炎症小体对死亡细胞及其代谢产物的激活反应。
Curr Opin Immunol. 2014 Oct;30:91-8. doi: 10.1016/j.coi.2014.09.001. Epub 2014 Oct 1.
7
A role for the NLRP3 inflammasome in metabolic diseases--did Warburg miss inflammation?NLRP3 炎性体在代谢性疾病中的作用——难道沃伯格错过了炎症?
Nat Immunol. 2012 Mar 19;13(4):352-7. doi: 10.1038/ni.2228.
8
Inflammasome Priming in Sterile Inflammatory Disease.免疫激活物预刺激在非感染性炎症性疾病中的作用。
Trends Mol Med. 2017 Feb;23(2):165-180. doi: 10.1016/j.molmed.2016.12.007. Epub 2017 Jan 18.
9
The inflammasome in atherosclerosis and type 2 diabetes.炎症小体在动脉粥样硬化和 2 型糖尿病中的作用。
Sci Transl Med. 2011 May 4;3(81):81ps17. doi: 10.1126/scitranslmed.3001902.
10
Innate immune receptors: key regulators of metabolic disease progression.先天免疫受体:代谢性疾病进展的关键调节因子。
Cell Metab. 2013 Jun 4;17(6):873-882. doi: 10.1016/j.cmet.2013.05.011.

引用本文的文献

1
Chronic inflammation in obesity and neurodegenerative diseases: exploring the link in disease onset and progression.肥胖与神经退行性疾病中的慢性炎症:探寻疾病发生与进展中的联系
Mol Biol Rep. 2025 Apr 25;52(1):424. doi: 10.1007/s11033-025-10509-z.
2
The Selective 3-MST Inhibitor I3MT-3 Works as a Potent Caspase-1 Inhibitor.选择性3-MST抑制剂I3MT-3作为一种有效的半胱天冬酶-1抑制剂发挥作用。
Int J Mol Sci. 2025 Mar 2;26(5):2237. doi: 10.3390/ijms26052237.
3
Exploring the Therapeutic Potential of Royal Jelly in Metabolic Disorders and Gastrointestinal Diseases.探讨蜂王浆在代谢紊乱和胃肠道疾病中的治疗潜力。
Nutrients. 2024 Jan 29;16(3):393. doi: 10.3390/nu16030393.
4
Reduction of SPARC protects mice against NLRP3 inflammasome activation and obesity.SPARC 的减少可保护小鼠免受 NLRP3 炎性小体激活和肥胖的影响。
J Clin Invest. 2023 Oct 2;133(19):e169173. doi: 10.1172/JCI169173.
5
Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities.重新构建代谢与 NLRP3 炎性小体之间的联系:治疗机会。
Front Immunol. 2023 Jul 20;14:1232629. doi: 10.3389/fimmu.2023.1232629. eCollection 2023.
6
Inflammasome in Skeletal Muscle: NLRP3 Is an Inflammatory Cell Stress Component in Inclusion Body Myositis.炎症小体在骨骼肌中的作用:NLRP3 是包涵体肌炎中炎性细胞应激的组成部分。
Int J Mol Sci. 2023 Jun 26;24(13):10675. doi: 10.3390/ijms241310675.
7
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders.肠道菌群:中药改善脂质代谢紊乱的新靶点。
Front Pharmacol. 2023 Mar 1;14:1134430. doi: 10.3389/fphar.2023.1134430. eCollection 2023.
8
Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.炎症小体在瘢痕疙瘩和增生性瘢痕中的作用——从慢性糖尿病创面和皮肤纤维化中得到的启示。
Int J Mol Sci. 2022 Jun 19;23(12):6820. doi: 10.3390/ijms23126820.
9
The Role of Inflammasomes in Osteoarthritis and Secondary Joint Degeneration Diseases.炎性小体在骨关节炎和继发性关节退行性疾病中的作用。
Life (Basel). 2022 May 13;12(5):731. doi: 10.3390/life12050731.
10
Disentangling Signatures of Selection Before and After European Colonization in Latin Americans.在拉丁美洲人群中解析欧洲殖民化前后选择的特征。
Mol Biol Evol. 2022 Apr 11;39(4). doi: 10.1093/molbev/msac076.

本文引用的文献

1
Unsolved Mysteries in NLR Biology.NLR生物学中的未解之谜。
Front Immunol. 2013 Sep 17;4:285. doi: 10.3389/fimmu.2013.00285.
2
Mechanisms of NOD-like receptor-associated inflammasome activation.NOD 样受体相关炎性小体激活的机制。
Immunity. 2013 Sep 19;39(3):432-41. doi: 10.1016/j.immuni.2013.08.037.
3
Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue.肥胖表型与 NLRP3 炎性体活性和内脏脂肪组织的免疫特征有关。
Diabetologia. 2013 Nov;56(11):2487-97. doi: 10.1007/s00125-013-3023-9. Epub 2013 Sep 7.
4
Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1α and sterile vascular inflammation in atherosclerosis.脂肪酸诱导的线粒体解偶联引发动脉粥样硬化中无炎症小体依赖性的 IL-1α 和无菌性血管炎症。
Nat Immunol. 2013 Oct;14(10):1045-53. doi: 10.1038/ni.2704. Epub 2013 Sep 1.
5
Autophagy and cellular immune responses.自噬与细胞免疫应答。
Immunity. 2013 Aug 22;39(2):211-27. doi: 10.1016/j.immuni.2013.07.017.
6
Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation.线粒体心磷脂对于 Nlrp3 炎性小体的激活是必需的。
Immunity. 2013 Aug 22;39(2):311-323. doi: 10.1016/j.immuni.2013.08.001. Epub 2013 Aug 15.
7
Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis.肥胖脂肪细胞表现出应激细胞的超微结构特征,并通过细胞焦亡而死亡。
J Lipid Res. 2013 Sep;54(9):2423-36. doi: 10.1194/jlr.M038638. Epub 2013 Jul 8.
8
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.CD36 通过促进无菌炎症中可溶性配体在细胞内成核为颗粒状配体,协调 NLRP3 炎性小体的激活。
Nat Immunol. 2013 Aug;14(8):812-20. doi: 10.1038/ni.2639. Epub 2013 Jun 30.
9
Immune effector mechanisms implicated in atherosclerosis: from mice to humans.与动脉粥样硬化相关的免疫效应机制:从老鼠到人。
Immunity. 2013 Jun 27;38(6):1092-104. doi: 10.1016/j.immuni.2013.06.009.
10
P2X7R: a potential key regulator of acute gouty arthritis.P2X7R:急性痛风性关节炎的潜在关键调节因子。
Semin Arthritis Rheum. 2013 Dec;43(3):376-80. doi: 10.1016/j.semarthrit.2013.04.007. Epub 2013 Jun 17.